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Abstract
Accounting for the effective dose (ED, mSv) and calculating the radiation risk
during CT is necessary to predict the long-term consequences of radiation exposure
on the population. We analyzed the results of 1003 CT examinations of the chest in
patients with suspected COVID-19 in the city diagnostic center. The average ED
and confidence intervals (p ≤ 0.05) for patients with a single CT scan were: children
(12–14 years) 2.59  0.19 mSv, adolescents (15–19 years) 3.23  0.17 mSv, adults
(20–64 years), 3.43  0.08 mSv, older persons (65 years and older)
3.28  0.19 mSv. The maximum radiation risk values were 31.2*10–5 in women
children and 29.3*10–5 in women adolescents, which exceeds the risk values for men
in these age groups by 2.3 and 1.9 times, respectively. For the group of adult patients
the risk was 11.2*10–5 in men and 17.4*10–5 in women, which is 1.6 times higher
than in men. All these risk values are in the range of 10*10–5–100*10–5, which
corresponds to the level LOW. For the group of older age patients, the radiation risk
was 2.6*10–5, which corresponds to the level of 1*10–5–10*10–5, VERY LOW. Our
materials shows in detail the technique to evaluate effective radiation doses for
chest CT and calculate the radiation risk of the carcinogenic effects of this exposure.
Keywords: computed tomography, chest CT diagnostics, effective dose, radiation
risks levels, the dependence of the radiation risk levels of sex and age
1. Introduction
In the coming years, due to the introduction of methods of medical diagnostics
and treatment using ionizing radiation, the growth of medical exposure of the
Russian population expected to continue, especially due to computed tomography
(CT). Therefore, it is important to evaluate radiation dose levels and population
radiation risks in the form of a possible oncological pathology among the population
in the long term after exposure [1–8].
Estimating the stochastic effects on the basis of a linear non-threshold model, P.
Galle [9] concluded that, compared to 700,000 spontaneous cancers per year, when
recalculated to the French population, 7,000 deadly cancers are caused by radiation
causes. Of these, 3,000 are associated with high concentrations in radon homes,
1,000- with radiation medical procedures, 10 - with radiation from the work of the
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nuclear industry and 1 - from increased natural radiation background. Therefore,
from medical exposure, 14.3% of all radiation-related oncological pathologies arise.
Due to the widespread use of CT of the chest organs for the diagnosis of COVID-
19, including during repeated examinations, this issue is of particular relevance.
The aim of the study was to assess effective radiation doses for chest CT for the
diagnosis of Covid-19 and calculate the radiation risk of the effects of this exposure.
2. Material and methods
2.1 General characteristics of patients
We analyzed the results of 1003 CT examinations of the chest performed in
patients with suspected COVID-19 during one week in October 2020 in the
city diagnostic center. Among these patients were 6.2% children in the ages of
12–14 years old, 15.3% adolescents in the ages of 15–19 years old, 60.1% adults in the
ages of 20–64 years old, and 18.4% older persons of ages 65 years and older. The
average ages and confidence intervals (p ≤ 0,05) were 13.8  0.20 years old in
group 1 (children), 17.1  0.41 years old in group 2 (adolescents); 45.8  1.47 years
old in group 3 (adults) (of which 41.8% are of ages 20–45 years old and 58.2% are of
ages 46–64 years old); 69.4  1.79 years old in group 4 (older persons). The
percentage number of male (female) persons in the groups are 51.6% (48.4%) in
group 1, 52.3% (47.7%) in group 2, 46.3% (53.7%) in group 3, 47% (53%) in group
4. The proportion of patients with CT signs of pneumonia and without pathological
signs amounted to a total of 54,6% and 45,4%, respectively, for each of the four age
groups. The distribution of the patients into groups during CT examination is given
in Table 1.














1.1. Men 32 15.6 84.4
1.2. Women 30 13.3 86.7
1. Total 62 14.5 85.5
2 Adolescents
(15–19)
2.1. Men 80 26.3 73.7
2.2. Women 73 21.9 78.1
2. Total 153 24.2 75.8
3 Adults
(20–64)
3.1. Men 279 55.6 44.4
3.2. Women 324 71.0 29.0




4.1. Men 87 77.0 23.0
4.2. Women 98 51.0 49.0





The distribution of patients in groups during CT examination on COVID-19.
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2.2 Description of computed tomography technique, calculation of effective
dose and radiation risk
CT studies of the chest were performed on a Siemens Somatom Emotion 16
scanner (16-slice) using a standard algorithm. The voltage on the tube was 130 kV
with automatic modulation of the amperage; the slice thickness was 0.8 mm (pitch
1.4) or 1.5 mm (pitch 1.2). Of each patient, the values of the parameters determin-
ing the radiation load were entered into the database CTDIvol (mGy), DLP
(mGy*cm) and ED, mSv.
The calculation of the effective dose (ED, mSv) for a single phase CT scan was
performed according to the following equation.
The CTDIvol values were entered into the database from the CT scanner con-
sole. Then, the DLP was calculated by the formula:




x irradiated length cmð Þ (1)
The procedure for registering the indicator “irradiated length (cm)” was as
follows. Previously, the X-ray technician performed an X-ray (tomogram) of the
chest. Then the region of interest (ROI) was installed on the CT scanner console in
accordance with the Recommendations of EUR16262, 1999 [10]: Volume of inves-
tigation (routine chest) - from lung apex to the base of the lungs. The length of this
area (irradiated length) was measured individually in each patient. In this area, a
CT scan was subsequently performed and, accordingly, the patient was irradiated.
DLP was calculated for this zone.
In our study, for the chest the “irradiated length” (Median, 25th and 75th
percentile) was (cm): 31.3 (30.1–33.4) - in children, 34.7 (32.6–36.6) - in adoles-
cents, 36.6 (34.9–38.7) - in adults, 33.3 (31.6–36.8) – for persons 65 years and older.
Then, using the DLP, the effective doses was estimated according to the
formula [11]:
ED,mSv ¼ KED DLP ∗DLP: (2)
To calculate the effective dose (ED, mSv) the chest KED DLP conversion factor
(mSv*mGy1 *cm1) used was KED DLP = 0.012 for both the children group (12–
14 years old) and the adolescent group (15–19 years old) and KED DLP = 0.016 for the
subjects older than 19 years [12, 13].
The method of calculating the risk of radiation consequences is based on the
analysis of the frequency of leukemia and other oncological diseases, hereditary
disorders in subsequent generations in the population after irradiation of people
during the atomic explosions in Hiroshima and Nagasaki, the Marshall Islands, after
gamma irradiation of patients with cancer and after incidents and accidents at
nuclear reactors. Several hundred publications with this information were summa-
rized in ICRP Publication 103, 2007 [11], and the risks of these consequences in
persons of different genders and ages were calculated depending on the radiation
dose received. In our study, calculations of radiation risk are carried out according
to the National Methodological Recommendations [14] as follows:
R ¼ ED ∗ r, (3)
where
R is the radiation risk per 100,000 population at an exposure dose of ED, mSv;
ED - effective dose, mSv;
r - risk indicator for exposure of 1 mSv (mSv1).
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A risk indicator for exposure of 1 mSv used, lifetime cancer risk of radiation is
5.5 * 105 mSv1 for the entire population regardless of age and sex. However, in
this study r (risk indicator) were used, taking into account the age and sex of
patients (Table 2) in accordance with the National Methodological Recommenda-
tions [14]. These values were calculated for the Russian population (mortality and
morbidity data for 2008) using risk models and ICRP calculation methods [11, 15].
When calculating Radiation risk level, the scales listed in Table 3 were used.
The mean and median values of effective doses in the formed groups were close,
the assessment of the data according to Kolmogorov–Smirnov test for normality and
Shapiro–Wilk’s W test showed that the nature of their distribution is close to
normal. The measured data were expressed as the average  confidence interval
(X  CI) at p ≤ 0.05, as well as median (Me, 25th and 75th percentile). The
significance of differences between the groups according to Student t-criterion, P
value<0.05 was considered for statistical significance. STATISTICA statistical soft-
ware (version 10.0; Stat Soft. Inc., United States) was used for analysis.
3. Results and discussion
The average effective doses to patients with a single CT scan in the formed
groups as illustrated in Table 4 and Figure 1A were 2.59  0.19 mSv in group 1
(children 12–14 years old), 3.23  0.17 mSv in group 2 (adolescents 15–19 years
Age, years Man Woman Age, years Man Woman
0–4 5,6*105 2,2*104 45–49 2,9*105 4,9*105
5–9 5,0*105 1,8*104 50–54 2,6*105 4,1*105
10–14 4,6*105 1,4*104 55–59 2,1*105 3,4*105
15–19 4,4*105 1,0*104 60–64 1,7*105 2,7*105
20–24 4,0*105 8,1*105 65–69 1,3*105 2,0*105
25–29 3,8*105 7,1*105 70–74 9,5*106 1,3*105
30–34 3,6*105 6,3*105 75–79 6,4*106 7,9*106
35–39 3,4*105 5,6*105 80–84 4,3*106 4,6*106
40–44 3,3*105 5,7*105 85+ 2,1*106 1,3*106
Table 2.
Lifetime risk of death ratios, taking into account harm from reduced quality of life, calculated [14] per 1 mSv
effective dose for medical diagnostic chest irradiation.
Radiation risk levels Radiation risk
Values Values per 100,000 people
NEGLIGIBLE <106 (less than 1 case per 1,000,000 people) < 0.1
MINIMUM 106–105 (1 to 10 cases per 1,000,000 people) 0.1–1
VERY LOW 105–104 (1 to 10 cases per 100,000 people) 1–10
LOW 104–103 (1 to 10 cases per 10,000 people) 10–100
MODERATE 103–3*103 (1 to 3 cases per 1,000 people) 100–300
Table 3.
The radiation risk levels (individual lifetime risk) to a patient’s health associated with medical exposure during
diagnostic studies or treatment procedures [14].
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Groups Age (years) Subgroups by sex ED, Me (25th; 75th percentile), mSv* ED, X  CI, mSv* Radiation risk
Cases, per 100,000 people Level
Calculating Values Criteria interval
1 Children (12–14) Men 2.65 (2.45; 2.96) 2.92  0.30 ED*4.6 13.4 10–100 LOW
Women 2.17 (1.88; 2.46) 2.23  0.16 ED*14.0* 31.2 10–100 LOW
Total 2.46 (2.13; 2.70) 2.59  0.19 ED*9.3* 24.1 10–100 LOW
2 Adolescents (15–19) Men 3.38 (3.01; 3.88) 3.50  0.23 ED*4.4 15.4 10–100 LOW
Women 2.51 (2.37; 3.15) 2.93  0.23 ED*10.0 29.3 10–100 LOW
Total 3.13 (2.37; 3.60) 3.23  0.17 ED*7.2 23.3 10–100 LOW
3 Adults (20–64) Men 3.69 (3.05; 4.10) 3.61  0.08 ED*3.1 11.2 10–100 LOW
Women 3.27 (2.42; 3.77) 3.28  0.13 ED*5.3 17.4 10–100 LOW
Total 3.39 (2.72; 3.93) 3.43  0.081,2 ED*4.2 14.4 10–100 LOW
4 Older people (65 and older) Men 3.15 (2.57; 3.90) 3.30  0.23 ED*0.7 2.3 1–10 VERY LOW
Women 3.26 (2.05; 4.20) 3.26  0.30 ED*0.9 2.9 1–10 VERY LOW
Total 3.21 (2.51; 3.90) 3.28  0.193,4 ED*0.8 2.6 1–10 VERY LOW
*Significance of differences mean values ED (X) between groups (p ≤ 0,05) 11 and 3, 22 and 3, 31 and 4, 42 and 4.
Table 4.




























































old), 3.43  0.08 mSv in group 3 (adults 19–64 years old) and 3.28  0.19 mSv in
group 4 (older persons – 65 years and older).
These doses are comparable with the ED values shown in the report [16] on the
evaluation of DRLs for adult CT in European countries and in studies of other
authors [17–19]. The DRLs for CT of adult chest organs in European countries were:
4.7–6.31 mSv in Netherlands [11, 14], 5.1–5.95 mSv in Germany [16, 18], 6.8 mSv in
Austria [16], 5.95–10.4 mSv in Great Britain [16, 19], 7.31 mSv in Finland [16], 8.5–
10.5 in Denmark [16], as well as 7.65 mSv in Australia [20].
In our earlier study [21], with standard protocols on different CT scanners, the
values of the ED were in the ranges of 2.4–6.04 mSv and 8.4–15.33 mSv, for a single-
phase and multiphase with contrast CTs, respectively. The use of low-dose pro-
tocols (tube voltage from 80 to 100 kV with automatic modulation of current)
made it possible to reduce the ED to 1.6 mSv, when applying the iterative recon-
struction algorithm MBIR for single-phase CTs and to 4.41 mSv when applying the
iterative reconstruction algorithm ASIR for multiphase CTs [22].
Based on the risk indicator value for exposure of 1 mSv with age and sex
(Table 3) were calculations radiation risk values and radiation risk levels after chest
CT radiation per 100,000 exposed persons (Table 4). The maximum radiation risk
values for a single CT were observed (Figure 1B) in groups of children (24.1*105)
and adolescents (23.3*105). As can be seen in Figure 2B, the radiation risk values
for a single CT were 31.2*105 in women children (12–14 years old) and 29.3*105 in
women adolescents (15–19 years old), which exceeds the risk values for men in
these groups by 2.3 and 1.9 times, respectively. For the group of adult patients the
(a) (b)
Figure 1.
Average doses, mSv (A), and radiation risk values by age groups of patients (B) with a single, double and triple
computed tomography of the chest. On the ordinate axis: (A) – average effective dose and confidence intervals
(p ≤ 0.05), mSv; (B) – values of radiation risk per 100,000 people; on the abscissa: age groups. Legend:
number of CT scans of the patient,  single,  double,  triple. The dashed lines show the boundaries
between the levels of radiation risk (*).
6
Computed Tomography Scan
average risk was 14.4*105, (11.2*105) in men and 17.4*105 in women, which is
1.6 times higher than in men. Nevertheless, all these risk values are in the range of
10*105–100*105, which corresponds to the level LOW. For the group of older age
patients, the radiation risk was 2.6*105, which corresponds to the leval rang of
1*105–10*105, VERY LOW.
We have compared the calculations with estimates of radiation risks in other
studies.
For example, when planning the limits of exposure of astronauts [23], the risk of
oncological diseases and genetic effects are rather low: 0.2*106 for leukemia,
0.2*106 for other types of malignant neoplasms, and 0.05*106 for genetic effects,




Average doses for a single CT scan (A), radiation risk values for a single (B), twice repeated (C) and triple (D)
CT, distribution by levels of radiation risk by age groups and depending on the sex of patients. On the ordinate
axis: (A) – average effective dose and confidence intervals (p ≤ 0.05), mSv; (B–D) – values of radiation risk
per 100,000 people; on the abscissa axis: age groups. Legend: – men, – women. The dashed lines show the
boundaries between the levels of radiation risk (*).
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50*106 for leukemia, 1000–2000*106 for other types of malignant neoplasms and
8000*106 for genetic effects per year.
In publication 103 of the ICRP [11], new views of the ICRP on the principles and
approaches to ensuring radiation safety, are formulated in comparison with the
previous document - Publication 60 of the ICRP [15]. Epidemiological data obtained
since the publication of Publication 60 of the ICRP served as a reason for revising
the values of the nominal risk factors per unit dose for radiogenic cancers and
hereditary effects (Table 5).
As we can see, the new risk values in Publication 103 are slightly lower as those
specified in Publication 60. But, at the same time, for children compared with
adults, they were increased in terms of Malignant neoplasms from 1.5 to 1.68, for
hereditary defects from 2.25 to 3.0, and in the total number of negative effects from
1.61 to 2.0. Our results are comparable to these guidelines.
I.A. Tsalafoutas, G.V. Koukourakis [24] emphasize that stochastic negative
effects can be caused even by small doses of radiation, and give the following
example of calculating the risk associated with radiation during CT. The assumption
of a 5% probability of risk per 1 Sv (1,000 mSv) for the occurrence of cancer or
hereditary effects means that the examination, which leads to patient exposure in
ED = 10 mSv (typical for CT of the abdomen and pelvis), implies 0.05% chance of
such risks. That is, for every 10,000 patients, who underwent CT with a dose of
10 mSv, five people can be expected, to develop cancer or hereditary effects as the
result of radiation.
There was calculation individual of effective dose and risk of malignancy based
on Monte Carlo simulations after whole body CT [25]. The Excess Relative Risk
(ERRMC), as a measurement of the exceeding risk of an exposed person compared
to a non-exposed person, calculated using the solid cancer mortality in the United
States as baseline (female: 17,500/100,000; male: 22,100/100,000).
There was calculation individual of Effective Dose and estimation of organ-
specific additional Lifetime Attributable Risk (LAR) of cancer mortality after
Whole Body Computed Tomography based on Monte Carlo simulations and report
VII about Biologic Effects of Ionizing Radiation (BEIR VII). Considering the effec-
tive doses of 1.48  0.15 mSv for the lungs, the LAR for mortality from lung cancer
[n / 100,000] was 13.25  4.24.
In our study, it was shown that with a single chest CT scan in patients with
suspected COVID-19, additional (to a spontaneous level) cases of oncological
pathology per 100,000 people may occur: 24.1 cases in children, 23.3 cases in
adolescents, 14.4 cases in adults, 2.6 cases in older persons.
The average effective dose will increase in proportion to the increase in the
number of CTs performed on the patient from 2.6–3.4 mSv with a single CT scan to
the calculated values of 7.8–10.3 mSv with three times CTs. This will lead to a
threefold increase in radiation risks to levels per 100,000 people may occur
Irradiated population Malignant neoplasms Hereditary effects Total
Publ. 103 Publ. 60 Publ. 103 Publ. 60 Publ. 103 Publ. 60
Whole population 5.5 6.0 0.2 1.3 6.0 7.3
Adults 4.1 4.8 0.1 0.8 4.0 5.6
Children 6.9 7.2 0.3 1.8 8.0 9.0
KAdults/ Children 1.68 1.5 3.0 2.25 2.0 1.61
Table 5.
Comparison of the risk of negative effects of exposure from a dose of 1 mSv, number of cases per 105 people
(ICRP Publication 103, 2007 [11]; ICRP Publication 60, 1991 [15]).
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(Figure 1B): 72.3 cases in children, 69.8 cases in adolescents, 43.2 cases in adults, 7.9
cases in older persons. Due to the increased post-radiation risks in children;
сcurrently, both the European and the American Society of Pediatric Radiology do
not recommend the use of CT to diagnose COVID-19 pneumonia in children. CT is
indicated only for severe, where concurrent pathology need to be excluded.
In men, the average radiation doses in the four age groups were slightly higher
than in women (Figure 2A). However, with an increase in the number of CT scans
from one (Figure 2B) to two (Figure 2C) and up to three (Figure 2D) in females,
the increase in the calculated radiation risk compared to men is more significant,
especially in women children (in 2.3 times) and among women adolescent (in 1.9
times). The radiation risk in men and women in all subgroups by age up to 65 years
remains at the LOW level (10*105–100*105), and in the older subgroup at the
WERY LOW level (1*105–10*105). However, with a three-fold CT scan in groups
of children and adolescents, the radiation risk in women approaches the border of
the MODERATE level (100*105–300*105), and in the old group to the border of
the LOW level (10*105–100*105).
By evaluating the lung irradiation with the doses used in the ongoing clinical
trials to treat COVID -19 patients, our data shows that a radiation dose 0.5 Gy
provides an acceptable Risk Identification Checklist (RIC) estimate (LAR 1%),
irrespective of sex and age at exposure [26]. However, a promising direction is the
use of modern CT scanners, which allow the use of low-dose algorithms for CT
diagnostics [27], while significantly reducing the radiation exposure to patients.
4. Conclusions
Because the study established effective radiation doses for chest CTs of patients
with the diagnosis of COVID-19, the radiation risks for a single, double and triple
chest CTs in different age and sex of patients were calculated. It has been found,
that the radiation risk due to a single, double and triple chest CTs for patients under
65 years old is LOW, and for 65 years old and older patents is VERY LOW. Taking
into account the radiation risk during CT is necessary to reduce the long-term
consequences of radiation exposure on the population.
Financing
The study was performed without external funding.
Conflict of interest
The authors declare no conflict of interest.
Conformity with the principles of ethics
The study was approved by the local ethics committee.
Abbreviations
ASIR Adaptive Statistical Iterative Reconstruction
9
Radiation Doses and Risk Assessment during Computed Tomography of the Chest in COVID-19…
DOI: http://dx.doi.org/10.5772/intechopen.100177
CT Computed tomography
CTDIvol Computed tomography dose index
DLP Dose length product
DRLs Diagnostic reference levels
ED Effective doses
ICRP International Commission on Radiological Protection
LAR Lifetime Attributable Risk
MBIR Model-Based Iterative Reconstruction
Author details
Elena Ivanovna Matkevich and Ivan Vasilievich Ivanov*
Department of Occupational Health, I.M. Sechenov First Moscow State Medical
University of the Ministry of Health of the Russian Federation (Sechenov
University), Moscow, Russian Federation
*Address all correspondence to: ivanov-iv@yandex.ru
©2021 TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,




[1]Demin VF, Biryukov AP,
Sedankin MK, Solov'ev VY. Specific risk
of radiogenic cancer for professionals.
Medical radiology and radiation
safety. 2020;65(2):17–20. (In Russ.).
DOI:10.12737/1024-6177-2020-65-
2-17-20.
[2] Linet MS, Slovis ThL, Miller DL,
Kleinerman R, Lee Ch, Rajaraman P,
et al. Cancer risks associated with
external radiation from diagnostic
imaging procedures. 2012; СA: Cancer J
Clin. 62(2):75–100. DOI:10.3322/
caac.21132.
[3] Smith-Bindman R, Lipson J,
Marcus R, Kim K-P, Mahesh M,
Gould R, et al. Radiation dose associated
with common computed tomography
examinations and the associated lifetime
attributable risk of cancer. 2009; Arch
Intern Med. 169(22):2078–86. DOI:
10.1001/archinternmed.2009.427.
[4]Mathews J.D., Forsythe A.V.,
Brady Z., Butler M.W., Goergen S.K.,
Byrnes G.B., et al. Cancer risk in
680000 people exposed to computed
tomography scans in childhood or
adolescence: data linkage study of 11
million Australians. BMJ. 2013;346:
f2360–f2378. DOI:10.1136/bmj.f2360.
[5] Brenner DJ, Elliston C, Hall E,
Berdon W. Estimated risks of
radiationinduced fatal cancer from
pediatric CT. Am J Roentgenol. 2001;
176(2):289–296. DOI:10.2214/
ajr.176.2.1760289.
[6]Hall EJ, Brenner DJ. Cancer risks
from diagnostic radiology. Br J Radiol.
2008;81(965):362–378, DOI:10.1259/bjr/
01948454.
[7]Hendee WR, O’Connor MK,
Radiation risks of medical imaging:
separating fact from fantasy. Radiology.
2012;264(2)312–321. DOI:10.1148/
radiol.12112678.
[8] Cardis E, Howe G, Ron E,
Bebeshko V, Bogdanova T, Bouville A,
et al. Cancer consequences of the
Chernobyl accident: 20 years on. J
Radiol Prot. 2006:26(2)127–140. DOI:
10.1088/0952-4746/26/2/001. PMID:
16738412.
[9] Galle P. The Sievert: an Enigmatic
Unit. Cell. Mol. Biol. (Noisy-le-grand).
2001:47(3)565–7. PMID: 11441965.
[10]EUR16262, 1999. European guidelines
on quality criteria in Computed
Tomography. Brussels, Belgium:
European Commission, Report EUR
16262. 1999. Available via: https://op.e
uropa.eu/da/publication-detail/-/publica
tion/d229c9e1-a967-49de-b169-59ee
68605f1a. (Accessed 17 August 2021).
[11] ICRP, 2007. The 2007
Recommendations of the International
Commission on Radiological Protection.
ICRP Publication 103. Ann. ICRP 2007;
37(2–4):1-332. https://www.icrp.org/
publication.asp?id=ICRP%20
Publication%20103 (Accessed 17 August
2021).
[12]Methodical guidelines MUK
2.6.7.3652-20. 2.6.7. Ionizing radiation,
health status of workers and population.
Control methods in CT diagnostics to




17 August 2021). (In Russ.).
[13]Methodical guidelines MU
2.6.1.2944-11. Ionizing radiation,
radiation safety. Monitoring of the
effective doses of patient due to medical
x-ray examinations. Moscow, 2011.




2970477 (Accessed 17 August 2021). (In
Russ.).
11
Radiation Doses and Risk Assessment during Computed Tomography of the Chest in COVID-19…
DOI: http://dx.doi.org/10.5772/intechopen.100177
[14] Assessment of radiation risk in
patients during X-ray and radiological
studies: Methodical recommendations




17 August 2021). (In Russ.).
[15] ICRP, 1991. 1990 Recommendations
of the International Commission on
Radiological Protection. ICRP
Publication 60. Ann. ICRP 21; 1991; 1–3:
1-211. http://www.icrp.org/publication.
asp?id=ICRP%20Publication%2060
(Accessed 17 August 2021).
[16]Damilakis J., Frija G., Hierath M.,
Jaschke W., Mayerhofer-Sebera U.,
Paulo G, et al. European Study on
Clinical Diagnostic Reference Levels for
X-ray Medical Imaging. Deliverable 2.1:
Report and review on existing clinical






[17]Molen AJ, Schilham A, Stoop P,
Prokop M, Geleijns J. A national survey
on radiation dose in CT in The
Netherlands. Insights Imaging. 2013; 4
(3):383–390. DOI: 10.1007/s13244-013-
0253-9.












node.html. (Accessed 01 August 2021).
[19] Shrimpton PC, Hillier MC,
Lewis MA, Dunn M. National survey of
doses from CT in the UK: 2003. Br. J.
Radiol. 2006; 79(948):968–980. DOI:
10.1259/bjr/93277434.
[20]Hayton A., Wallace A., Marks P.,
Edmonds K., Tingey D & Johnston P.
Australian diagnostic reference levels
for multi detector computed
tomography. Australas. Phys. Eng. Sci.
Med. 2013;36(1):19–26. DOI:10.1007/
s13246-013-0180-6.
[21]Matkevich EI, Sinitsyn VE,
Bashkov AN, Comparison of Radiation
Dose of Patients During Single-phase
and Multiphase Computed Tomography
in the Multidisciplinary Treatment
Clinic. Medical Radiology and Radiation
Safety. 2016;61(6)50–6. http://medrad
iol.fmbafmbc.ru/vypuski?id=231.
(Accessed 17 August 2021). (In Russ.).
[22]Matkevich EI, Sinitsyn VE,
Zelikman MI, Kruchinin SA, Ivanov IV.
Main directions of reducing patient
irradiation doses in computed
tomography. Russian Electronic Journal
of Radiology (REJR). 2018;8(3):60–73.
DOI: 10.21569/2222-7415-2018-8-3-60-
73. (In Russ.).
[23]Grigoriev YuG. Long-term effects of
radiation damage. In: Radiation safety of
space flights. Radiobiological aspects.
Moscow, Atomizdat, 1975, P. 40–4. (In
Russ.).
[24] Tsalafoutas IA, Koukourakis GV.
Patient dose considerations in computed
tomography examinations. World J.
Radiol. 2010;2(7):262–268, DOI:
10.4329/wjr.v2.i7.262.
[25] Kopp M, Loewe T, Wuest W,
Brand M, Wetzl M., Nitsch W, et al.
Individual calculation of effective dose
and risk of malignancy based on Monte
Carlo simulations after whole body
Computed tomography. Scientific
Reports. 2020;10,9475. DOI: 10.1038/
s41598-020-66366-2.
[26] Arruda GA, Weber RRS, Bruno
AC&Pavoni JF. The risk of induced
12
Computed Tomography Scan
cancer and ischemic heart disease
following low dose lung irradiation for
COVID-19: estimation based on a virtual
case. International Journal of Radiation
Biology. 2021;97(2):120–125. DOI:
10.1080/09553002.2021.1846818.
[27]Matkevich EI, Sinitsyn VE,
Ivanov IV. Optimization of radiation




Radiation Doses and Risk Assessment during Computed Tomography of the Chest in COVID-19…
DOI: http://dx.doi.org/10.5772/intechopen.100177
